Synthetic Molecules Show Promise Against Deadly Fungal Infections

A new study reveals that lab-made molecules could help combat dangerous fungal infections that threaten vulnerable patients. These synthetic compounds, designed to mimic natural immune fighters, successfully attacked Candida albicans—a common fungus that turns deadly in people with weakened immunity.

The Fungal Threat

• C. albicans causes 4 in 10 hospital deaths when infections spread

• Current antifungals are toxic, hard to administer, and losing effectiveness

• Fungi are evolutionarily similar to humans, making drug development tough

"Targeting fungi is like disarming a bomb—we share too many cellular structures with them," explains Dr. Andrej Spec, a fungal infection expert at Washington University.

The Synthetic Solution

Researchers created polymer peptides (LH) that:
✔ Pierce fungal cell membranes
✔ Damage critical cell wall proteins
✔ Work alongside existing drugs like caspofungin

Key breakthrough:

• Alone: LH reduced infection markers by 20%

• Combined with caspofungin: 98% reduction in cell damage

• 
  

Real-World Potential

• In wax moth models (a stand-in for human infection), the combo boosted survival rates

• Early tests show no signs of fungal resistance—a major advantage

• Could allow lower doses of harsh antifungals, reducing side effects

• 
  

Why It Matters

For immunocompromised patients (e.g., chemotherapy recipients, organ transplant patients):
✅ Fewer toxic treatments
✅ More options when standard drugs fail
✅ Potential to save thousands of lives annually

Next Steps

• Identify the exact molecular target of LH to optimize design

• Test safety and efficacy in mammals

• 
  

• Explore other polymer-drug combinations

"This isn’t a silver bullet yet, but it’s a new weapon in our arsenal," says microbiologist Sascha Brunke, co-lead researcher.

Reference:

1. Schaefer, S. et al. A synthetic peptide mimic kills Candida albicans and synergistically prevents infection. Nat Commun  15,6818 (2024).
2. Mazi, P.B. et al. Attributable mortality of Candida bloodstream infections in the modern era: A propensity score analysis. Clin Infect Dis  75, 1031-1036 (2022).
3. Huan, Y., Kong, Q., Mou H., & Yi, H. Antimicrobial peptides: Classification, design, application and research progress in multiple fields. Front Microbiol  11 (2020).